Farshid Dayyani, MD, University of California Irvine School of Medicine
Advertisement
Articles by Farshid Dayyani, MD, University of California Irvine School of Medicine
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Pumitamig Plus Chemo Demonstrates Encouraging Efficacy in Frontline NSCLC
2
In Vivo CD19/CD20 CAR T-Cell Therapy Is Safe, Yields 100% ORR at Phase 1, Dose Level 2 in R/R Non-Hodgkin Lymphomas
3
Experts Weigh In on Some of the Most Impactful Data in Melanoma From ASCO 2026
4
A global, randomized, double-blinded, Phase 3 trial of vorasidenib vs placebo in patients with grade 2 glioma with an IDH1/2 mutation (INDIGO): updated efficacy and safety
5